Form 4: CFO Bragg Granted Stock Options

CFO Kimberly Bragg acquired stock options in Imunon, Inc. on August 4, 2025.

Summary

• Kimberly Bragg, CFO of Imunon, Inc., was granted stock options to purchase 667 shares of common stock on August 4, 2025.
• The exercise price of the options is $9.20 per share, which was the closing price of Imunon, Inc. common stock on the grant date.
• The options vest as follows: 1/2 on the date of grant, 1/4 on the one-year anniversary of the grant date, and 1/4 on the two-year anniversary of the grant date.
• The options expire on August 4, 2035.
• A 1-for-15 reverse stock split was effected on July 25, 2025, which adjusted the share amounts and exercise prices of outstanding equity awards.

Sentiment

Score: 6

Explanation: Neutral. The filing simply reports the grant of stock options, a routine event. It is a positive for the executive, but not necessarily indicative of overall company performance.

Positives

• Grant of stock options to the CFO aligns her interests with those of the shareholders.
• Vesting schedule incentivizes continued service and contribution to the company's success over the next two years.

Future Outlook

NA

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry to incentivize performance and align management interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Vesting schedules typically range from 2 to 4 years, with the described vesting schedule being within the normal range.
• Comparable companies such as BioNTech, Moderna, and Novavax also utilize stock options as part of their executive compensation packages.

Stakeholder Impact

• Shareholders: Potential dilution if options are exercised.
• Employees: May view the option grant as a positive sign of management's confidence in the company.
• Management: Incentivized to improve company performance to increase the value of the options.

Key Dates

Recommendation

The grant of stock options to the CFO is a routine event and does not significantly alter the investment thesis for the stock. A hold recommendation is appropriate.

Keywords

stock options, Form 4, Imunon, IMNN, CFO, Kimberly Bragg, equity awards, reverse stock split